Reporting Manager
Soleus Capital Master Fund, L.P.
Symbol
RIGL
Shares outstanding
17,666,859 shares
Disclosed Ownership
1,130,679 shares
Ownership
6.4%
Form type
SCHEDULE 13G/A
Filing time
11 Feb 2025, 16:00:35 UTC
Date of event
31 Dec 2024
Next filing
05 Aug 2025

Quoteable Key Fact

"Soleus Capital Master Fund, L.P. disclosed 6.4% ownership in RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL) on 31 Dec 2024."

Quick Takeaways

  • Soleus Capital Master Fund, L.P. filed SCHEDULE 13G/A for RIGEL PHARMACEUTICALS, INC. Common Stock, $0.001 par value per share (RIGL).
  • Disclosed ownership: 6.4%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 11 Feb 2025, 16:00.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (6)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Soleus Capital Master Fund, L.P. 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital, LLC 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Group, LLC 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus Capital Management, L.P. 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Soleus GP LLC 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy/Managing Member
Guy Levy 6.4% 1,130,679 0 1,130,679 /s/ Guy Levy Guy Levy